Allianz Asset Management’s Fate Therapeutics FATE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-24,918
| Closed | -$617K | – | 1521 |
|
2022
Q2 | $617K | Sell |
24,918
-30,806
| -55% | -$763K | ﹤0.01% | 1622 |
|
2022
Q1 | $2.16M | Buy |
55,724
+1,255
| +2% | +$48.6K | ﹤0.01% | 1348 |
|
2021
Q4 | $3.2M | Buy |
54,469
+22,945
| +73% | +$1.35M | ﹤0.01% | 1261 |
|
2021
Q3 | $1.87M | Buy |
31,524
+1,111
| +4% | +$65.8K | ﹤0.01% | 1393 |
|
2021
Q2 | $2.64M | Sell |
30,413
-14,231
| -32% | -$1.24M | ﹤0.01% | 1229 |
|
2021
Q1 | $3.68M | Sell |
44,644
-964
| -2% | -$79.5K | ﹤0.01% | 1088 |
|
2020
Q4 | $4.15M | Buy |
+45,608
| New | +$4.15M | ﹤0.01% | 1088 |
|
2020
Q2 | – | Sell |
-31,670
| Closed | -$703K | – | 1925 |
|
2020
Q1 | $703K | Sell |
31,670
-12,931
| -29% | -$287K | ﹤0.01% | 1544 |
|
2019
Q4 | $873K | Buy |
44,601
+654
| +1% | +$12.8K | ﹤0.01% | 1770 |
|
2019
Q3 | $682K | Sell |
43,947
-64,619
| -60% | -$1M | ﹤0.01% | 1798 |
|
2019
Q2 | $2.2M | Sell |
108,566
-983
| -0.9% | -$20K | ﹤0.01% | 1516 |
|
2019
Q1 | $1.93M | Buy |
109,549
+1,188
| +1% | +$20.9K | ﹤0.01% | 1553 |
|
2018
Q4 | $1.39M | Buy |
108,361
+229
| +0.2% | +$2.94K | ﹤0.01% | 1578 |
|
2018
Q3 | $1.76M | Buy |
+108,132
| New | +$1.76M | ﹤0.01% | 1608 |
|
2016
Q3 | – | Sell |
-18,252
| Closed | -$31K | – | 2037 |
|
2016
Q2 | $31K | Sell |
18,252
-179,077
| -91% | -$304K | ﹤0.01% | 1988 |
|
2016
Q1 | $355K | Sell |
197,329
-11,978
| -6% | -$21.5K | ﹤0.01% | 1774 |
|
2015
Q4 | $705K | Buy |
209,307
+16,711
| +9% | +$56.3K | ﹤0.01% | 1651 |
|
2015
Q3 | $1.03M | Buy |
+192,596
| New | +$1.03M | ﹤0.01% | 1493 |
|